StonvexLoading…
StonvexStonvexStonvexCore line items from IRDM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $871.66M | $830.68M | $790.72M | $721.03M |
Operating Income | $235.98M | $200.38M | $81.63M | $76.68M |
Net Income | $114.37M | $112.78M | $15.41M | $8.72M |
EPS (Diluted) | $1.06 | $0.94 | $0.12 | $0.07 |
Total Assets | $2.53B | $2.67B | $2.66B | $2.95B |
Total Liabilities | $2.07B | $2.09B | $1.77B | $1.83B |
Cash & Equivalents | $96.50M | $93.53M | $71.87M | $168.77M |
Free Cash Flow OCF − CapEx | $299.79M | $306.06M | $241.43M | $273.46M |
Shares Outstanding | 107.84M | 110.36M | 122.78M | 125.90M |